WilliamThomasJohnsonDO

PubMed

• 69 citations
  Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.
  Melissa R Hines, Tristan E Knight, Kevin O McNerney, Mark B Leick, Tania Jain
  Transplantation and Cellular Therapy. 2023-07-01
• 86 citations
  Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.
  Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder, Nivetha Ganesan, Esther Drill
  Journal of Clinical Oncology. 2021-06-25
• 16 citations
  Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation.
  William T. Johnson, Parth Patel, Amanda Hernandez, Lisa M. Grandinetti, Arthur C. Huen
  Journal of Cutaneous Pathology. 2016-03-01